80 FR 8331 - National Cancer Institute; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 80, Issue 31 (February 17, 2015)
National Institutes of Health
Federal Register Volume 80, Issue 31 (February 17, 2015)
| Page Range | 8331-8332 | |
| FR Document | 2015-03092 |
[Federal Register Volume 80, Number 31 (Tuesday, February 17, 2015)] [Notices] [Pages 8331-8332] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-03092] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant and/or proposal applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; R13 Conference Grant Review. Date: March 3, 2015. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W556, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Bratin K. Saha, Ph.D., Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W556, Rockville, MD 20850, 240-276-6411, [email protected]. Name of Committee: National Cancer Institute Special Emphasis Panel; Core Infrastructure & Methodological Research for Cancer Epidemiology Cohorts (U01). Date: March 12, 2015. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 6W032, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Viatcheslav A. Soldatenkov, Ph.D., M.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W254, Bethesda, MD 20892-8329, 240-276-6378, [email protected]. Name of Committee: National Cancer Institute Special Emphasis Panel; Vacutubes to Preserve the Viability of Circulating Tumor Cells. Date: March 19, 2015. Time: 10:30 a.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W538, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Ivan Ding, M.D., Health Scientist Administrator, Program & Review Extramural Staff Training Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W534, Bethesda, MD 20892-9750, 240-276-6444, [email protected]. Name of Committee: National Cancer Institute Special Emphasis Panel; Predictive Biomarkers of Adverse Reactions to Radiation Treatment. Date: March 20, 2015. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W538, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Ivan Ding, M.D. Health Scientist Administrator, Program & Review Extramural Staff Training Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W534, Bethesda, MD 20892-9750, 240-276-6444, [email protected]. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Small Grants Program for Cancer Research. Date: March 24-25, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Viatcheslav A. Soldatenkov, Ph.D., M.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W254, Bethesda, MD 20892-8329, 240-276-6378, [email protected]. Name of Committee: National Cancer Institute Special Emphasis Panel; AIDs Malignancy Consortium (AMC). Date: March 26-27, 2015. Time: 6:30 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Bratin K. Saha, Ph.D., Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W556, Rockville, MD 20850, 240-276-6411, [email protected]. Name of Committee: National Cancer Institute Special Emphasis Panel; Cancer Intervention and Surveillance Modeling. Date: April 1-2, 2015. Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W554, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Christopher L. Hatch, Ph.D., Chief, Health Scientific Administrator, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W554, Rockville, MD 20850, 240-276- 6454, [email protected]. Information is also available on the Institute's/Center's home page: http://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; [[Page 8332]] 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: February 10, 2015. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015-03092 Filed 2-13-15; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 80, No. 31 / Tuesday, February 17, 2015 / Notices 8331
Contact Person: Sally Eckert-Tilotta, Ph.D., The meetings will be closed to the Date: March 20, 2015.
Scientific Review Officer, National Institute public in accordance with the Time: 11:00 a.m. to 3:00 p.m.
of Environmental Health Sciences, Office of provisions set forth in sections Agenda: To review and evaluate grant
Program Operations, Scientific Review applications.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Place: National Cancer Institute Shady
Branch, P.O. Box 12233, Research Triangle
Park, NC 27709, (919) 541–1446, eckertt1@
as amended. The grant and/or proposal Grove, 9609 Medical Center Drive, Room
niehs.nih.gov. applications and the discussions could 7W538, Rockville, MD 20850, (Telephone
(Catalogue of Federal Domestic Assistance
disclose confidential trade secrets or Conference Call).
Program Nos. 93.115, Biometry and Risk commercial property such as patentable Contact Person: Ivan Ding, M.D. Health
Estimation—Health Risks from material, and personal information Scientist Administrator, Program & Review
Environmental Exposures; 93.142, NIEHS concerning individuals associated with Extramural Staff Training Branch, Division of
Hazardous Waste Worker Health and Safety the grant applications, the disclosure of Extramural Activities, National Cancer
Training; 93.143, NIEHS Superfund Institute, 9609 Medical Center Drive, Room
which would constitute a clearly
Hazardous Substances—Basic Research and 7W534, Bethesda, MD 20892–9750, 240–276–
unwarranted invasion of personal 6444, dingi@mail.nih.gov.
Education; 93.894, Resources and Manpower privacy.
Development in the Environmental Health Name of Committee: National Cancer
Sciences; 93.113, Biological Response to Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Small
Environmental Health Hazards; 93.114, Institute Special Emphasis Panel; R13 Grants Program for Cancer Research.
Applied Toxicological Research and Testing, Conference Grant Review. Date: March 24–25, 2015.
National Institutes of Health, HHS) Date: March 3, 2015. Time: 8:00 a.m. to 5:00 p.m.
Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant
Dated: February 10, 2015. Agenda: To review and evaluate contract applications.
Carolyn Baum, proposals. Place: Hyatt Regency Bethesda, One
Program Analyst, Office of Federal Advisory Place: National Cancer Institute Shady Bethesda Metro Center, 7400 Wisconsin
Committee Policy. Grove, 9609 Medical Center Drive, Room Avenue, Bethesda, MD 20814.
7W556, Rockville, MD 20850, (Telephone Contact Person: Viatcheslav A.
[FR Doc. 2015–03094 Filed 2–13–15; 8:45 am]
Conference Call). Soldatenkov, Ph.D., M.D., Scientific Review
BILLING CODE 4140–01–P Contact Person: Bratin K. Saha, Ph.D., Officer, Special Review Branch, Division of
Scientific Review Officer, Program Extramural Activities, National Cancer
Coordination and Referral Branch, Division Institute, NIH, 9609 Medical Center Drive,
DEPARTMENT OF HEALTH AND of Extramural Activities, National Cancer Room 7W254, Bethesda, MD 20892–8329,
HUMAN SERVICES Institute, 9609 Medical Center Drive, Room 240–276–6378, soldatenkovv@mail.nih.gov.
7W556, Rockville, MD 20850, 240–276–6411,
Name of Committee: National Cancer
National Institutes of Health sahab@mail.nih.gov.
Institute Special Emphasis Panel; AIDs
Name of Committee: National Cancer Malignancy Consortium (AMC).
National Institute on Aging; Amended Institute Special Emphasis Panel; Core Date: March 26–27, 2015.
Notice of Meeting Infrastructure & Methodological Research for Time: 6:30 p.m. to 4:00 p.m.
Cancer Epidemiology Cohorts (U01). Agenda: To review and evaluate grant
Notice is hereby given of a change in Date: March 12, 2015. applications.
the meeting of the National Institute on Time: 10:00 a.m. to 6:00 p.m. Place: Bethesda North Marriott Hotel &
Agenda: To review and evaluate grant Conference Center 5701 Marinelli Road,
Aging Special Emphasis Panel, April 06,
applications. Bethesda, MD 20852.
2015, 11:00 a.m. to April 06, 2015, 1:00 Place: National Cancer Institute Shady
p.m., National Institute on Aging, Contact Person: Bratin K. Saha, Ph.D.,
Grove, 9609 Medical Center Drive, Room Scientific Review Officer, Program
Gateway Building, 7201 Wisconsin 6W032, Rockville, MD 20850, (Telephone Coordination and Referral Branch, Division
Avenue, Suite 2C212, Bethesda, MD Conference Call). of Extramural Activities, National Cancer
20892 which was published in the Contact Person: Viatcheslav A. Institute, NIH, 9609 Medical Center Drive,
Federal Register on February 9, 2015, Soldatenkov, Ph.D., M.D., Scientific Review Room 7W556, Rockville, MD 20850, 240–
80 FR 7003. Officer, Special Review Branch, Division of
276–6411, sahab@mail.nih.gov.
Extramural Activities, National Cancer
The meeting notice is amended to Institute, 9609 Medical Center Drive, Room Name of Committee: National Cancer
change the date of the meeting from 7W254, Bethesda, MD 20892–8329, 240–276– Institute Special Emphasis Panel; Cancer
April 6, 2015 to March 30, 2015. The 6378, soldatenkovv@mail.nih.gov. Intervention and Surveillance Modeling.
meeting is closed to the public. Date: April 1–2, 2015.
Name of Committee: National Cancer
Time: 12:00 p.m. to 4:00 p.m.
Dated: February 10, 2015. Institute Special Emphasis Panel; Vacutubes
Agenda: To review and evaluate grant
to Preserve the Viability of Circulating Tumor
Melanie J. Gray, applications.
Cells.
Program Analyst, Office of Federal Advisory Date: March 19, 2015. Place: National Cancer Institute Shady
Committee Policy. Time: 10:30 a.m. to 2:30 p.m. Grove, 9609 Medical Center Drive, Room
Agenda: To review and evaluate grant 7W554, Rockville, MD 20850, (Telephone
[FR Doc. 2015–03091 Filed 2–13–15; 8:45 am]
applications. Conference Call).
BILLING CODE 4140–01–P Contact Person: Christopher L. Hatch,
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room Ph.D., Chief, Health Scientific Administrator,
7W538, Rockville, MD 20850, (Telephone Program Coordination and Referral Branch,
DEPARTMENT OF HEALTH AND Conference Call). Division of Extramural Activities, National
HUMAN SERVICES Contact Person: Ivan Ding, M.D., Health Cancer Institute, NIH, 9609 Medical Center
Scientist Administrator, Program & Review Drive, Room 7W554, Rockville, MD 20850,
National Institutes of Health Extramural Staff Training Branch, Division of 240–276–6454, ch29v@nih.gov.
Extramural Activities, National Cancer Information is also available on the
tkelley on DSK3SPTVN1PROD with NOTICES
National Cancer Institute; Notice of Institute, 9609 Medical Center Drive, Room Institute’s/Center’s home page: http://
Closed Meetings 7W534, Bethesda, MD 20892–9750, 240–276– deainfo.nci.nih.gov/advisory/sep/sep.htm,
6444, dingi@mail.nih.gov. where an agenda and any additional
Pursuant to section 10(d) of the Name of Committee: National Cancer information for the meeting will be posted
Federal Advisory Committee Act, as Institute Special Emphasis Panel; Predictive when available.
amended (5 U.S.C. App.), notice is Biomarkers of Adverse Reactions to (Catalogue of Federal Domestic Assistance
hereby given of the following meetings. Radiation Treatment. Program Nos. 93.392, Cancer Construction;
VerDate Sep<11>2014 16:51 Feb 13, 2015 Jkt 235001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 E:\FR\FM\17FEN1.SGM 17FEN1](https://thefederalregister.org/doc/80_FR_8362/page/1.svg)
![8332 Federal Register / Vol. 80, No. 31 / Tuesday, February 17, 2015 / Notices
93.393, Cancer Cause and Prevention Boulevard, Rockville, MD 20852, (Telephone DHHS, Room 4227, MSC 9550, 6001
Research; 93.394, Cancer Detection and Conference Call). Executive Boulevard, Bethesda, MD 20892–
Diagnosis Research; 93.395, Cancer Contact Person: Jagadeesh S. Rao, Ph.D., 9550, (301) 435–1439, lf33c.nih.gov.
Treatment Research; 93.396, Cancer Biology Scientific Review Officer, Office of
Research; 93.397, Cancer Centers Support; Name of Committee: National Institute on
Extramural Affairs, National Institute on
93.398, Cancer Research Manpower; 93.399, Drug Abuse, National Institutes of Health, Drug Abuse Special Emphasis Panel;
Cancer Control, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room Interventions for Youth Who Misuse/Abuse
HHS) 4234, MSC 9550, Bethesda, MD 02892, 301– Prescription Stimulant Medications in High
Dated: February 10, 2015. 443–9511, jrao@nida.nih.gov. School and/or College-Attending Youth
Name of Committee: National Institute on (U01).
Melanie J. Gray,
Drug Abuse Special Emphasis Panel; NIDA Date: March 31, 2015.
Program Analyst, Office of Federal Advisory Core ‘‘Center of Excellence’’ Grant Program Time: 8:30 a.m. to 4:30 p.m.
Committee Policy. (P30). Agenda: To review and evaluate grant
[FR Doc. 2015–03092 Filed 2–13–15; 8:45 am] Date: March 10, 2015. applications.
BILLING CODE 4140–01–P Time: 8:30 a.m. to 4:00 p.m. Place: Hilton Garden Inn Bethesda, 7301
Agenda: To review and evaluate grant Waverly Street, Bethesda, MD 20814.
applications.
Contact Person: Susan O. McGuire, Ph.D.,
DEPARTMENT OF HEALTH AND Place: NIAID Conference Center, 5609
Scientific Review Officer, Office of
HUMAN SERVICES Fisher’s Lane, Rockville, MD 20852.
Contact Person: Nadine Rogers, Ph.D., Extramural Affairs, National Institute on
Scientific Review Officer, Office of Drug Abuse, National Institutes of Health,
National Institutes of Health
Extramural Affairs, National Institute on DHHS, 6001 Executive Blvd., Room 4245,
National Institute on Drug Abuse; Drug Abuse, NIH, DHHS, 6001 Executive Rockville, MD 20852, 301–435–1426,
Notice of Closed Meetings Blvd., Room 4229, MSC 9550, Bethesda, MD mcguireso@mail.nih.gov.
20892–9550, 301–402–2105, rogersn2@ Name of Committee: National Institute on
Pursuant to section 10(d) of the nida.nih.gov. Drug Abuse Special Emphasis Panel; The
Federal Advisory Committee Act, as Name of Committee: National Institute on National Drug Abuse Treatment Clinical
amended (5 U.S.C. App), notice is Drug Abuse Special Emphasis Panel; NIDA Trials Network (UG1).
hereby given of the following meetings. Research ‘‘Center of Excellence’’ Grant Date: March 31, 2015.
The meetings will be closed to the Program (P50).
Time: 8:30 a.m. to 5:00 p.m.
public in accordance with the Date: March 11, 2015.
Time: 8:30 a.m. to 4:00 p.m. Agenda: To review and evaluate
provisions set forth in sections cooperative agreement applications.
552b(c)(4) and 552b(c)(6), title 5 U.S.C., Agenda: To review and evaluate grant
applications. Place: National Institutes of Health,
as amended. The grant applications and Place: NIAID Conference Center, 5609 Neuroscience Center, 6001 Executive
the discussions could disclose Fisher’s Lane, Rockville, MD 20852. Boulevard, Rockville, MD 20852.
confidential trade secrets or commercial Contact Person: Nadine Rogers, Ph.D., Contact Person: Jose F. Ruiz, Ph.D.,
property such as patentable material, Scientific Review Officer, Office of Scientific Review Officer, Office of
and personal information concerning Extramural Affairs, National Institute on Extramural Affairs, National Institute on
individuals associated with the grant Drug Abuse, NIH, DHHS, 6001 Executive Drug Abuse, NIH, Room 4228, MSC 9550,
applications, the disclosure of which Blvd., Room 4229, MSC 9550, Bethesda, MD 6001 Executive Blvd., Bethesda, MD 20892–
would constitute a clearly unwarranted 20892–9550, 301–402–2105, rogersn2@
9550, (301) 451–3086, ruizjf@nida.nih.gov.
invasion of personal privacy. nida.nih.gov.
Name of Committee: National Institute on Name of Committee: National Institute on
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; R13 Drug Abuse Special Emphasis Panel; Avenir
Drug Abuse Special Emphasis Panel; Conference Grant Review (PA13–347). Award Program for Genetics or Epigenetics of
Extracellular Vesicles in HIV/AIDS and Date: March 17, 2015. Substance Abuse (DP2).
Substance Abuse (R01, R21). Time: 2:00 p.m. to 4:00 p.m. Date: April 13, 2015.
Date: February 26, 2015.
Agenda: To review and evaluate grant Time: 9:00 a.m. to 5:00 p.m.
Time: 8:00 a.m. to 5:00 p.m.
applications. Agenda: To review and evaluate grant
Agenda: To review and evaluate grant
Place: National Institutes of Health, applications.
applications.
Neuroscience Center, 6001 Executive Place: Hilton Garden Inn Bethesda, 7301
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852. Boulevard, Rockville, MD 20852, (Virtual Waverly Street, Bethesda, MD 20814.
Contact Person: Jagadeesh S. Rao, Ph.D., Meeting).
Contact Person: Gerald L. McLaughlin,
Scientific Review Officer, Office of Contact Person: Minna Liang, Ph.D.,
Scientific Review Officer, Grants Review Ph.D., Scientific Review Officer, Office of
Extramural Affairs, National Institute on Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health, Branch, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH, Drug Abuse, NIH, DHHS, 6001 Executive
DHHS, 6001 Executive Boulevard, Room
DHHS, 6001 Executive Blvd., Room 4226, Blvd., Room 4238, MSC 9550, Bethesda, MD
4234, MSC 9550, Bethesda, MD 02892, 301–
443–9511, jrao@nida.nih.gov. MSC 9550, Bethesda, MD 20892–9550, 301– 20892–9550, 301–402–6626, gm145a@
This notice is being published less than 15 435–1432, liangm@nida.nih.gov. nih.gov.
days prior to the meeting due to the timing Name of Committee: National Institute on (Catalogue of Federal Domestic Assistance
limitations imposed by the review and Drug Abuse Special Emphasis Panel; Loan Program Nos.: 93.279, Drug Abuse and
funding cycle. Repayment 2015. Addiction Research Programs, National
Name of Committee: National Institute on Date: March 30, 2015. Institutes of Health, HHS)
Drug Abuse Special Emphasis Panel; Time: 9:00 a.m. to 2:00 p.m.
Exploratory Studies of Smoking Cessation Agenda: To review and evaluate grant Dated: February 9, 2015.
applications.
tkelley on DSK3SPTVN1PROD with NOTICES
Interventions for People with Schizophrenia Michelle Trout,
(R21/R33). Place: National Institutes of Health,
Program Analyst, Office of Federal Advisory
Date: March 3, 2015. Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Virtual Committee Policy.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant Meeting). [FR Doc. 2015–03095 Filed 2–13–15; 8:45 am]
applications. Contact Person: Lyle Furr, Scientific BILLING CODE 4140–01–P
Place: National Institutes of Health, Review Officer, Office of Extramural Affairs,
Neuroscience Center, 6001 Executive National Institute on Drug Abuse, NIH,
VerDate Sep<11>2014 16:51 Feb 13, 2015 Jkt 235001 PO 00000 Frm 00048 Fmt 4703 Sfmt 9990 E:\FR\FM\17FEN1.SGM 17FEN1](https://thefederalregister.org/doc/80_FR_8362/page/2.svg)
Document Created: 2015-12-18 13:19:46
Document Modified: 2015-12-18 13:19:46
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | March 3, 2015. | |
| FR Citation | 80 FR 8331 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR